0000950170-24-022581.txt : 20240228
0000950170-24-022581.hdr.sgml : 20240228
20240228215623
ACCESSION NUMBER: 0000950170-24-022581
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240227
FILED AS OF DATE: 20240228
DATE AS OF CHANGE: 20240228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DAWES KAREN A
CENTRAL INDEX KEY: 0001261506
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-14656
FILM NUMBER: 24698567
MAIL ADDRESS:
STREET 1: 579 BELLEVUE AVE
CITY: NEWPORT
STATE: RI
ZIP: 02840
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REPLIGEN CORP
CENTRAL INDEX KEY: 0000730272
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 042729386
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 7814499560
MAIL ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
4
1
ownership.xml
4
X0508
4
2024-02-27
0000730272
REPLIGEN CORP
RGEN
0001261506
DAWES KAREN A
C/O REPLIGEN CORPORATION
41 SEYON ST., BLDG 1, STE 100
WALTHAM
MA
02453
true
false
false
false
false
Common Stock
2024-02-27
4
M
false
4626
42.07
A
88367
D
Common Stock
2024-02-27
4
S
false
1000
193.35
D
87367
D
Stock Option (Right to Buy)
42.07
2024-02-27
4
M
false
4626
0.00
A
2028-05-16
Common Stock
4626
0
D
This option is fully vested and exercisable.
/s/ Kimberly Brown (Attorney in Fact)
2024-02-28